Anna Lena Illert

2.7k total citations
55 papers, 830 citations indexed

About

Anna Lena Illert is a scholar working on Oncology, Hematology and Molecular Biology. According to data from OpenAlex, Anna Lena Illert has authored 55 papers receiving a total of 830 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Oncology, 21 papers in Hematology and 19 papers in Molecular Biology. Recurrent topics in Anna Lena Illert's work include Chronic Myeloid Leukemia Treatments (12 papers), Acute Myeloid Leukemia Research (10 papers) and Cancer Genomics and Diagnostics (9 papers). Anna Lena Illert is often cited by papers focused on Chronic Myeloid Leukemia Treatments (12 papers), Acute Myeloid Leukemia Research (10 papers) and Cancer Genomics and Diagnostics (9 papers). Anna Lena Illert collaborates with scholars based in Germany, United States and Austria. Anna Lena Illert's co-authors include Paul Säftig, Kurt Von Figura, Yoshitaka Tanaka, Judith Blanz, Eeva‐Liisa Eskelinen, Günter Schwarzmann, Justus Duyster, Christian Peschel, Stefanie Kreutmair and Teresa Poggio and has published in prestigious journals such as Journal of Biological Chemistry, Nature Genetics and The Journal of Experimental Medicine.

In The Last Decade

Anna Lena Illert

49 papers receiving 817 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Anna Lena Illert Germany 15 338 231 168 131 118 55 830
Laura Oliva Italy 12 849 2.5× 399 1.7× 220 1.3× 141 1.1× 266 2.3× 19 1.3k
Charlotte A. Brown United States 22 489 1.4× 208 0.9× 85 0.5× 170 1.3× 77 0.7× 44 1.0k
Wanxia Li Tsai United States 11 329 1.0× 91 0.4× 53 0.3× 132 1.0× 84 0.7× 22 796
Gayathri Swaminathan United States 13 514 1.5× 95 0.4× 144 0.9× 237 1.8× 54 0.5× 21 898
Shoko Kuroda Japan 17 363 1.1× 174 0.8× 126 0.8× 198 1.5× 47 0.4× 24 1.1k
Naoko Suenaga Japan 13 394 1.2× 80 0.3× 170 1.0× 299 2.3× 92 0.8× 17 981
Lei Bi China 11 629 1.9× 60 0.3× 63 0.4× 200 1.5× 169 1.4× 45 1.1k
Hye‐Sook Kwon United States 12 423 1.3× 141 0.6× 32 0.2× 198 1.5× 148 1.3× 25 1.1k
Kimberly D. Klarmann United States 20 682 2.0× 95 0.4× 91 0.5× 280 2.1× 195 1.7× 30 1.2k
Jean‐Paul Feugeas France 20 580 1.7× 137 0.6× 57 0.3× 392 3.0× 42 0.4× 44 1.1k

Countries citing papers authored by Anna Lena Illert

Since Specialization
Citations

This map shows the geographic impact of Anna Lena Illert's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anna Lena Illert with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anna Lena Illert more than expected).

Fields of papers citing papers by Anna Lena Illert

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anna Lena Illert. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anna Lena Illert. The network helps show where Anna Lena Illert may publish in the future.

Co-authorship network of co-authors of Anna Lena Illert

This figure shows the co-authorship network connecting the top 25 collaborators of Anna Lena Illert. A scholar is included among the top collaborators of Anna Lena Illert based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anna Lena Illert. Anna Lena Illert is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Rieke, Damian, Michael Bitzer, Annalen Bleckmann, et al.. (2025). Precision oncology – Guideline of the Austrian, German and Swiss Societies for hematology and medical oncology. European Journal of Cancer. 220. 115331–115331.
2.
Schmidt, Carla, Luc Friboulet, Antoine Hollebecque, et al.. (2025). Saturation mutagenesis identifies activating and resistance-inducing FGFR kinase domain mutations. Nature Genetics. 58(1). 157–168.
3.
Metzger, Péter, et al.. (2024). PM4Onco: personalisierte Medizin für die Onkologie. Online Publication Service of Würzburg University (Würzburg University). 30(10). 898–904.
4.
Dreyer, Tobias, Kai J. Borm, Ulrich A. Schatz, et al.. (2024). Expert-Guided Large Language Models for Clinical Decision Support in Precision Oncology. JCO Precision Oncology. 8(8). e2400478–e2400478. 16 indexed citations
5.
Dreyer, Tobias, Sebastian Lange, Nicole Pfarr, et al.. (2024). Large language models for precision oncology: Clinical decision support through expert-guided learning.. Journal of Clinical Oncology. 42(16_suppl). e13609–e13609. 1 indexed citations
6.
Rassner, Michael, Tony Andreas Müller, Geoffroy Andrieux, et al.. (2024). STAT5-Activating Oncogenes Drive Oncostatin M Production Causing T Cell Exhaustion and Suppressive Myeloid Cell Recruitment. Blood. 144(Supplement 1). 4119–4119.
7.
Boerries, Melanie, et al.. (2024). Molekulare Tumorboards. Forum. 39(1). 33–37. 1 indexed citations
8.
Metzger, Patrick, Martin Werner, Cornelius Miething, et al.. (2024). Primary Results of Patients with Genitourinary Malignancies Presented at a Molecular Tumor Board. Urologia Internationalis. 108(5). 383–391.
9.
Werner, Rudolf A., Alexander Haug, Christian Buske, et al.. (2024). CXCR4-targeted Theranostics in Hematooncology: Opportunities and Challenges. Nuklearmedizin - NuclearMedicine. 63(2). 57–61. 2 indexed citations
10.
Metzger, Péter, et al.. (2024). Sondersituation der Daten in der Onkologie. mediaTUM (Technical University of Munich). 30(5). 347–352. 1 indexed citations
11.
Metzger, Patrick, V. Schipperges, Jan Christoph, et al.. (2023). MIRACUM-Pipe: An Adaptable Pipeline for Next-Generation Sequencing Analysis, Reporting, and Visualization for Clinical Decision Making. Cancers. 15(13). 3456–3456. 10 indexed citations
12.
Ammann, Sandra, Gianni Monaco, Lei Lei, et al.. (2023). Gene editing of hematopoietic stem cells restores T-cell response in familial hemophagocytic lymphohistiocytosis. Journal of Allergy and Clinical Immunology. 153(1). 243–255.e14. 8 indexed citations
13.
Kreutmair, Stefanie, Lena J. Lippert, Corinna Albers, et al.. (2022). NIPA (Nuclear Interaction Partner of ALK) Is Crucial for Effective NPM-ALK Mediated Lymphomagenesis. Frontiers in Oncology. 12. 875117–875117. 1 indexed citations
14.
Kreutmair, Stefanie, Dietmar Pfeifer, Miguel Waterhouse, et al.. (2022). First-in-human study of WT1 recombinant protein vaccination in elderly patients with AML in remission: a single-center experience. Cancer Immunology Immunotherapy. 71(12). 2913–2928. 20 indexed citations
15.
Kreutmair, Stefanie, Teresa Poggio, Geoffroy Andrieux, et al.. (2020). Existence of reprogrammed lymphoma stem cells in a murine ALCL-like model. Leukemia. 34(12). 3242–3255. 4 indexed citations
16.
Shoumariyeh, Khalid, Teresa Poggio, Dietmar Pfeifer, et al.. (2019). A novel conditional NPM-ALK-driven model of CD30+ T-cell lymphoma mediated by a translational stop cassette. Oncogene. 39(9). 1904–1913. 2 indexed citations
17.
Poggio, Teresa, Verónica I. Dumit, Stefanie Kreutmair, et al.. (2019). Proteomic Phosphosite Analysis Identified Crucial NPM-ALK-Mediated NIPA Serine and Threonine Residues. International Journal of Molecular Sciences. 20(16). 4060–4060. 5 indexed citations
18.
Kreutmair, Stefanie, Andrea Schmidts, Gabriele Ihorst, et al.. (2018). APC/CCdh1 regulates the balance between maintenance and differentiation of hematopoietic stem and progenitor cells. Cellular and Molecular Life Sciences. 76(2). 369–380. 5 indexed citations
19.
Müller, Tony Andreas, Rebekka Grundler, Rouzanna Istvánffy, et al.. (2016). Lineage-specific STAT5 target gene activation in hematopoietic progenitor cells predicts the FLT3+-mediated leukemic phenotype. Leukemia. 30(8). 1725–1733. 14 indexed citations
20.
Gorantla, Sivahari Prasad, Katja Zirlik, Andreas Reiter, et al.. (2015). F604S exchange in FIP1L1-PDGFRA enhances FIP1L1-PDGFRA protein stability via SHP-2 and SRC: a novel mode of kinase inhibitor resistance. Leukemia. 29(8). 1763–1770. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Laura Oliva Breakdown of academic impact, for papers by Charlotte A. Brown Breakdown of academic impact, for papers by Wanxia Li Tsai Breakdown of academic impact, for papers by Gayathri Swaminathan Breakdown of academic impact, for papers by Shoko Kuroda Breakdown of academic impact, for papers by Naoko Suenaga Breakdown of academic impact, for papers by Lei Bi Breakdown of academic impact, for papers by Hye‐Sook Kwon Breakdown of academic impact, for papers by Kimberly D. Klarmann Breakdown of academic impact, for papers by Jean‐Paul Feugeas
Rankless by CCL
2026